Garmpis, N.; Damaskos, C.; Garmpi, A.; Georgakopoulou, V.E.; Sarantis, P.; Antoniou, E.A.; Karamouzis, M.V.; Nonni, A.; Schizas, D.; Diamantis, E.;
et al. Histone Deacetylase Inhibitors in the Treatment of Hepatocellular Carcinoma: Current Evidence and Future Opportunities. J. Pers. Med. 2021, 11, 223.
https://doi.org/10.3390/jpm11030223
AMA Style
Garmpis N, Damaskos C, Garmpi A, Georgakopoulou VE, Sarantis P, Antoniou EA, Karamouzis MV, Nonni A, Schizas D, Diamantis E,
et al. Histone Deacetylase Inhibitors in the Treatment of Hepatocellular Carcinoma: Current Evidence and Future Opportunities. Journal of Personalized Medicine. 2021; 11(3):223.
https://doi.org/10.3390/jpm11030223
Chicago/Turabian Style
Garmpis, Nikolaos, Christos Damaskos, Anna Garmpi, Vasiliki E. Georgakopoulou, Panagiotis Sarantis, Efstathios A. Antoniou, Michalis V. Karamouzis, Afroditi Nonni, Dimitrios Schizas, Evangelos Diamantis,
and et al. 2021. "Histone Deacetylase Inhibitors in the Treatment of Hepatocellular Carcinoma: Current Evidence and Future Opportunities" Journal of Personalized Medicine 11, no. 3: 223.
https://doi.org/10.3390/jpm11030223
APA Style
Garmpis, N., Damaskos, C., Garmpi, A., Georgakopoulou, V. E., Sarantis, P., Antoniou, E. A., Karamouzis, M. V., Nonni, A., Schizas, D., Diamantis, E., Koustas, E., Farmaki, P., Syllaios, A., Patsouras, A., Kontzoglou, K., Trakas, N., & Dimitroulis, D.
(2021). Histone Deacetylase Inhibitors in the Treatment of Hepatocellular Carcinoma: Current Evidence and Future Opportunities. Journal of Personalized Medicine, 11(3), 223.
https://doi.org/10.3390/jpm11030223
